Cargando…
Antiviral Innate Immunity: Introduction
The concept of ‘innate immunity’ embraces all sorts of measures that exclude, inhibit, or slow down infections with little specificity and without adaptation or generation of a long-lasting memory. The mammalian innate immune defenses described in this article comprise defensins, the complement syst...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157471/ http://dx.doi.org/10.1016/B978-0-12-801238-3.02608-8 |
_version_ | 1783522349770866688 |
---|---|
author | Weber, F. |
author_facet | Weber, F. |
author_sort | Weber, F. |
collection | PubMed |
description | The concept of ‘innate immunity’ embraces all sorts of measures that exclude, inhibit, or slow down infections with little specificity and without adaptation or generation of a long-lasting memory. The mammalian innate immune defenses described in this article comprise defensins, the complement system, nonspecific phagocytic and cytolytic leukocytes (macrophages, monocytes, granulocytes, natural killer cells, and dendritic cells), and cytokines such as the antivirally active interferons. Since the type I interferon (IFN-α/β) system is our primary defense against viral infections, special attention will be paid to the virus-triggered induction of IFN transcription, the signaling activated by IFNs, and the antiviral factors expressed as a consequence |
format | Online Article Text |
id | pubmed-7157471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71574712020-04-15 Antiviral Innate Immunity: Introduction Weber, F. Reference Module in Biomedical Sciences Article The concept of ‘innate immunity’ embraces all sorts of measures that exclude, inhibit, or slow down infections with little specificity and without adaptation or generation of a long-lasting memory. The mammalian innate immune defenses described in this article comprise defensins, the complement system, nonspecific phagocytic and cytolytic leukocytes (macrophages, monocytes, granulocytes, natural killer cells, and dendritic cells), and cytokines such as the antivirally active interferons. Since the type I interferon (IFN-α/β) system is our primary defense against viral infections, special attention will be paid to the virus-triggered induction of IFN transcription, the signaling activated by IFNs, and the antiviral factors expressed as a consequence 2014 2014-11-28 /pmc/articles/PMC7157471/ http://dx.doi.org/10.1016/B978-0-12-801238-3.02608-8 Text en Copyright © 2014 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Weber, F. Antiviral Innate Immunity: Introduction |
title | Antiviral Innate Immunity: Introduction |
title_full | Antiviral Innate Immunity: Introduction |
title_fullStr | Antiviral Innate Immunity: Introduction |
title_full_unstemmed | Antiviral Innate Immunity: Introduction |
title_short | Antiviral Innate Immunity: Introduction |
title_sort | antiviral innate immunity: introduction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157471/ http://dx.doi.org/10.1016/B978-0-12-801238-3.02608-8 |
work_keys_str_mv | AT weberf antiviralinnateimmunityintroduction |